KOV-21

KOV-21 is a COVID-19 vaccine developed in India. It was created by the Indian pharmaceutical company Zydus Cadila, which is part of the Zydus Group. This vaccine is notable because it is a DNA plasmid vaccine, which is a different technology compared to the mRNA and viral vector vaccines that have been widely used. KOV-21 has been aimed primarily at providing immunity against the SARS-CoV-2 virus, which causes COVID-19.